I have diabetes and ED. Do the Goldstein numbers mean Levitra 10 mg is the one I should take?
A review that skips QT is a torn page
Holds first, then the scores. A glowing 10 mg write-up that never writes the rhythm line is advertising with a bibliography.
A Levitra 10 mg review that opens on 'it works' and never reaches QT is the kind of page I throw back. Of course it works. It is a PDE5 inhibitor. Placebo-controlled trials used the same IIEF erectile-function domain and the same SEP2/SEP3 intercourse questions the rest of the class used. That is necessary. It is not sufficient.
The distinctive evidence on this molecule is not a higher success league table. It is a labeled QT caution that the two tablets which boxed Levitra in 2003 print more quietly. Therapeutic 10 mg and a supratherapeutic 80 mg dose both lengthened QTc in a dedicated study of 59 healthy men, in the same neighborhood as moxifloxacin 400 mg. A later combination study showed additivity with another QT-active drug.
I write the practical box in the margin before I quote any IIEF delta. Congenital long QT: avoid. Class IA antiarrhythmics - quinidine, procainamide - avoid. Class III - amiodarone, sotalol - avoid. That is not a vibe. That is the label. Staxyn carries the same box. A melt does not wash the interval clean.
The swallowed profile, including the current wording I counsel from, sits on the vardenafil medicine page. This note is the evidence margin: what the trials measured, what the diabetes subset actually showed, and why a review without QT is half a page.
Peer line: if a man arrives with a printout that ranks 'Levitra 10 mg reviews' by star count and never lists his amiodarone, I treat the printout as unread. Stars do not read a med list.
What Goldstein actually counted in diabetes
Goldstein's 2003 diabetes trial is the reprint I pull when a man with diabetes has been told 'those pills do not work for us.' Diabetes Care. 452 men. Type 1 or type 2 plus ED. Fixed 10 mg or 20 mg versus placebo, as needed, twelve weeks. Not a lifestyle blog. A phase III.
Improved erections on the global question: 57 percent at 10 mg, 72 percent at 20 mg, 13 percent on placebo. Final IIEF erectile-function scores: 17.1 and 19.0 versus 12.6. Penetration and intercourse success both separated from placebo. The benefit showed across baseline severity, across HbA1c bands, and in both diabetes types.
I do not file that as 'vardenafil is the diabetes PDE5.' I file it as 'this short-acting tablet has a dedicated difficult-subset study at the 10 mg start and at 20 mg.' Sildenafil and tadalafil have diabetes data too. The counseling use is simpler: microvascular disease lowers class response, and a documented placebo gap still exists if the dose is real and the plate is not a steak.
Twenty milligrams was the stronger arm. I will escalate after a fair 10 mg trial if the holds are clean. I will not open a diabetic man at 20 mg to chase a headline. Glucose work stays parallel. A tablet does not replace an HbA1c conversation. Anyone who wants the clock-and-plate rules for that trial to be a fair trial should read the light-plate timing note.
Headache, flushing, rhinitis - the usual class noise, mostly mild or moderate in that study. That is not a reason to skip QT screening. Adverse-event tables and interval cautions are different drawers.
Class I and class III sit in the same box
Class IA drugs such as quinidine and procainamide, and class III drugs such as amiodarone and sotalol, are not a trivia list. They are the vardenafil-specific exclusion I actually use.
Class IA drugs such as quinidine and procainamide sit in the same labeled box as class III drugs such as amiodarone and sotalol. I do not split that box because a man 'only uses sotalol sometimes.' Sometimes is enough. Congenital long QT is the other half of the same sentence.
The millisecond moves in healthy men were modest. Modest is how torsades stories start when you add a second QT-active drug, a low potassium, or a CYP3A4 inhibitor that pushes vardenafil levels up. I do not scare routine men into an ECG for a clean med list. I do scare sloppy combinations.
Strong CYP3A4 inhibitors - ketoconazole, itraconazole, ritonavir and kin - raise exposure. That can turn a 10 mg start into something closer to the high-dose QT study than the man thinks he took. Dose reduction or avoidance is a label call, not a vibe. Grapefruit is the sloppy cousin. I ask.
Nitrates remain the class-wide hard stop. I mention them in an evidence note because reviews that obsess over QT and forget nitroglycerin have failed a more lethal exam. PDE5 plus a nitrate can cause profound hypotension. There is no clever review that makes that stack reasonable.
FDA wording lives on the FDA site and on DailyMed. I send men there when they want the current paragraph rather than my ink. If they want how the tablet even arrived in 2003, that is the origin file, not this review.
Head-to-head is thinner than people want
| Row I actually use | Vardenafil 10 mg start | Sildenafil | Tadalafil |
|---|---|---|---|
| Clock | About 30-60 min; ~4-5 h useful | About 30-60 min; ~4 h | About 30-45 min; long tail |
| Heavy plate | Slows and blunts | Slows and blunts | No meaningful food effect |
| Usual labeled steps | 5 / 10 / 20 mg (desk lock 5-10) | 25 / 50 / 100 mg | 10 / 20 mg or 2.5 / 5 daily |
| Visual complaints | Less often the reason to stop | Blue tinge more often | Uncommon |
| QT language | Labeled; avoid long QT, class I/III | Quieter | Quieter |
People want a winner among the three common PDE5 tablets. The comparison stack is thinner than the internet. Most of what we have is placebo-controlled work with the same instruments, plus small crossovers, plus a lot of kinetic common sense.
Average success looks similar when the dose is adequate and the trial is fair. Vardenafil behaves like sildenafil on the clock: half an hour to an hour in, a few hours of useful effect, a high-fat meal that slows and blunts. Tadalafil is the long outlier and the only one with a labeled daily habit.
I use a trade-off table, not a trophy table. Duration. Food. Visual side effects. QT. Those rows change a pick. A one-point IIEF gap in a small crossover does not.
Least visual side effects is a common switch reason onto vardenafil. PDE6 selectivity is the pharmacology story behind the blue tinge on sildenafil. I treat that as a counseling asset, not as a primary endpoint from Goldstein. If a man hated the tinge, a 10 mg vardenafil trial is rational - after the QT box is empty.
The visual switch and the sibling pages
Blue-tinge complaints after sildenafil are the most human reason I reach for this folder. The man is not asking for a more potent dish. He is asking for an evening that does not look wrong. Cheap vardenafil 10 mg is a reasonable next mark if the rhythm list is clean.
I still say the siblings out loud. Sildenafil if the man already has a rhythm and a price he likes. Tadalafil if the couple is tired of clocks. Vardenafil if the short window fits and the QT box is empty. The sibling pages are sildenafil and tadalafil. I will not paste those monographs into this review.
No daily vardenafil label exists. Anyone asking for a 'every morning 10 mg' habit is asking for tadalafil's job or for an off-label experiment I will not run from a library note. Once in twenty-four hours is the vardenafil ceiling.
Staxyn can enter an evidence review only as a formulation asterisk. Higher exposure. Same QT box. Same nitrate ban. Not a way to dodge the interval. Discretion is a delivery preference, not a safety upgrade.
How I file a 10 mg evidence note
I file the 10 mg evidence in a fixed order so I do not get seduced by a success rate. First the exclusions: nitrates, long QT, class I, class III, the ugly CYP3A4 combinations. Then the diabetes reprint if the man has diabetes. Then the kinetic rows. Then whether a visual switch is the actual reason we are here.
This site's medicine page locks 5-10 mg. I keep that lock in view so a review does not drift into a 20 mg advertisement. Twenty milligrams is a labeled step after a fair start. It is not the review's headline.
Generic price is evidence of a market, not of a trial. I will say cheap vardenafil 10 mg is often the reason a plan will fill this instead of a first brand. I will not say cheap is a reason to skip the QT line. Reviews that bury the interval under a coupon are the pages I called torn.
Last ink on this blotter: talk to the clinician who has your list before you change a tablet or a dose. A margin is a teaching mark. It is not your prescription.
What the numbers do not settle
Numbers do not erase a nitrate. They do not erase amiodarone. They do not turn a steak-and-ten-minutes night into a failed drug. I get letters that treat one bad evening as a meta-analysis. I send those letters back to the timing note.
They also do not pick a winner. If a man is QT-safe, wants a short window, and hated a visual effect, Levitra 10 mg is a coherent choice. If he wants a weekend, I am not loyal to this folder. Loyalty to a molecule is how reviews go bad.
I will keep citing Goldstein when diabetes is the doubt. I will keep citing the QT study when the med list is the doubt. I will not cite a star average. That is not how this desk files evidence.
Reader mail
Reader questions on this article
Answered by Dr. Julian Frost, MD · Urology & men's sexual health
Evidence-margin questions. I answer with the QT box open. A review that hides the interval is not a review I will sign.
They mean a dedicated trial at 10 mg and 20 mg beat placebo in men with diabetes, including across HbA1c bands. They do not mean this tablet is uniquely better than the other PDE5 drugs in that population. I still open the nitrate question and the QT box first. If those are clean, a 10 mg start on a light plate is a reasonable first mark. I escalate only after a fair trial. I also keep working the glucose. A reprint does not replace that. The swallowed profile is on the vardenafil page.
Which PDE5 tablet is the strongest if I just want the one that works?
There is no honest strongest. Average efficacy sits in the same band when the dose is adequate. What changes is the clock, the plate, the visual noise, the QT language, and the price. League-table thinking is how men double a tablet after one rushed night. I would rather you time a 10 mg start correctly than chase a mythical top step. If the first fair trial fails, we talk. We do not invent a champion from a forum.
What is the QT warning in a sentence I can actually use?
Vardenafil can lengthen the QT interval a little, and the label tells men with congenital long QT or on class I or class III antiarrhythmics to avoid it. Class I here means drugs such as quinidine and procainamide. Class III means drugs such as amiodarone and sotalol. If none of that is you, I still want the full list because CYP3A4 inhibitors raise levels. If that is you, I pick a sibling. I do not bargain the box because a review was glowing.
Can I use my nitrate spray on a night I also take Levitra 10 mg?
No. Not a little. Not 'if the chest pain is bad.' PDE5 plus a nitrate can cause profound hypotension. That is true for vardenafil, sildenafil, and tadalafil. If you take a PDE5 tablet, the emergency team needs the name and the clock before anyone reaches for nitroglycerin. There is no evidence review that makes this stack safer. I will not write a workaround in a consult thread.
Are the head-to-head studies good enough to pick Levitra 10 mg over the others?
No. They are thin. I pick on fit. Short window and a visual complaint after sildenafil: vardenafil is in play if QT is clear. Weekend and no clock: tadalafil. A man already stable on a cheap sildenafil habit: I do not switch him for a brochure. Small crossovers exist. They rarely change a first prescription in my room. Lifestyle rows beat a statistical tie.
What else besides nitrates and QT drugs should I put on the list?
Strong CYP3A4 inhibitors. Alpha-blockers, because blood pressure can stack - I often start 5 mg there, which is why this desk locks 5-10 on the medicine page. Grapefruit if it is a habit. Any new antifungal, HIV regimen, or antiarrhythmic after the first fill. Recheck the list when a cardiology or infectious-disease clinic adds a drug. The 10 mg you tolerated in March can be a different exposure in June.
If the three tablets are similar, why would you write vardenafil at all?
Switch after a blue tinge. Short-acting preference. A plan that will fill cheap vardenafil 10 mg. Staxyn if discretion matters and the man does not need a 5 mg start. I will not write it when the QT box is occupied. I will not write it as a daily habit. Those are specific reasons, not a brand loyalty. Document the clean list. Then give the trial more than one night.
Do I need an ECG before a first 10 mg tablet?
Not routinely, if the history and the list are clean. I order more paper when the story is messy: unexplained syncope, a family long-QT tale, a drug I cannot classify in the room. The label's point is the combination risk, not a screening industry. Bring the list. That is the test most men actually need.
Does Staxyn change the evidence or only the swallow?
Mostly the swallow and the exposure. Same PDE5, same QT box, same nitrate ban, higher levels than a swallowed Levitra 10 mg. No 5 mg ODT. I do not treat a melt as a way around the interval or as a faster onset. If a review praises Staxyn and never mentions QT, it is the same torn page with a different texture.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.
Last Updated